Efficient targeted anticoagulant with active RGD motif.

Area of Science:

• Biochemistry
• Pharmacology
• Molecular Biology

Background:

• Hirudin is a potent thrombin inhibitor.
• The Arg-Gly-Asp (RGD) motif plays a crucial role in platelet aggregation.
• Developing novel anticoagulants with enhanced efficacy is a significant clinical need.

Purpose of the Study:

• To generate and characterize novel recombinant hirudin variants incorporating the RGD motif.
• To evaluate the antithrombin and antiplatelet activities of these modified hirudins.
• To explore the structural basis of RGD-hirudin activity through computational modeling.

Main Methods:

• Chemical synthesis of RGD-hirudin variants by conjugating RGD sequences to hirudin.
• In vitro assays to measure antithrombin and antiplatelet activities.
• Computer simulations to analyze the structure of the active RGD motif.

Main Results:

• Three RGD-hirudin variants (RGD-hirudin 1, 2, and 3) were successfully synthesized.
• All variants demonstrated significant antithrombin and antiplatelet activities.
• RGD-hirudin 1 and 2 exhibited notably lower IC50 values compared to previously reported analogs.
• Computer simulation revealed a triangular structure for the active RGD motif.

Conclusions:

• RGD-hirudin 1 and 2 represent promising candidates for clinical anticoagulant therapy.
• The structural insights into the RGD motif may advance understanding of integrin-related interactions.
• This study highlights the potential of combining hirudin with RGD motifs for improved anticoagulant drugs.